RJF vs TVRD · rev $15.91B vs rev $2.6M
RJF (RJF) versus Tvardi Therapeutics, Inc. (TVRD) — a side-by-side from cached financials, not a winner call.
RJF (RJF) common stock.
Tvardi Therapeutics, Inc. (TVRD) is a biotechnology company listed on US.
Latest reported RJF revenue for 2025-09-30 was $15.91B. Net income was $2.13B. Revenue was up 6.6% from 2024-09-30 to 2025-09-30. RJF currently screens at market cap $0.
Latest reported TVRD revenue for 2025-03-31 was $2.6M. Net income was -$4.9M. TVRD currently screens at market cap $0.
RJF currently screens at market cap $0. TVRD currently screens at market cap $0.
Not investment advice. Open the RJF and TVRD stock pages for the full models.
Not investment advice.